A detailed history of Findlay Park Partners LLP transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Findlay Park Partners LLP holds 470,900 shares of MEDP stock, worth $146 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares
470,900
Previous 475,900 1.05%
Holding current value
$146 Million
Previous $196 Million 19.88%
% of portfolio
1.62%
Previous 1.97%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$320.58 - $457.29 $1.6 Million - $2.29 Million
-5,000 Reduced 1.05%
470,900 $157 Million
Q2 2024

Aug 13, 2024

BUY
$372.0 - $424.34 $94 Million - $107 Million
252,600 Added 113.12%
475,900 $196 Million
Q1 2024

Apr 30, 2024

BUY
$284.87 - $413.31 $63.6 Million - $92.3 Million
223,300 New
223,300 $90.2 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.66B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Findlay Park Partners LLP Portfolio

Follow Findlay Park Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Findlay Park Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Findlay Park Partners LLP with notifications on news.